Description
GLP3-RT (Retatrutide) is a triple-agonist research peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. This novel compound has generated significant interest in metabolic research due to its multi-receptor activity profile.
All Luxor Research peptides are manufactured under strict GMP-compliant conditions, independently tested by accredited U.S. laboratories, and guaranteed at 99%+ purity via HPLC and Mass Spectrometry analysis. A Certificate of Analysis is included with every order.
Supplied as a lyophilized powder. Store at 2-8°C for optimal stability. For in vitro research and laboratory use only. Not for human consumption.
